Using tumor-derived organoids to estimate how well cancer patients will respond to chemo

A team of researchers with members from across the Netherlands has found that using organoids derived from patient tumors can be used to help determine how well a cancer patient will respond to chemotherapy. In their paper published in the journal Science Translational Medicine, the group describes growing organoids from tumor tissue and testing them with chemo drugs. […]

View Original Source at Using tumor-derived organoids to estimate how well cancer patients will respond to chemo